Sandra M Gurrola
CIK 1618457 · Sr. VP of Finance · last filed 2025-07-07
Sandra M Gurrola is a Sr. VP of Finance who has filed 46 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for ERNA, was dated Jul 7, 2025. Current disclosed insider exposure totals $153.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$153.8K
3
46
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ERNA | Sr. VP of Finance | 110 | $6.15 | $676 | $0 | 5 | 2025-07-07 |
| BTX | Vice President of Finance | 16,953 | $9.03 | $153.1K | $0 | 4 | 2022-06-23 |
| Ernexa Therapeutics Inc. (NTN) Delisted | Former SVP of Finance | 21,617 | $2.70 | $58.4K | $0 | 35 | 2021-03-26 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-07 | ERNA | Exer (M) | +30 | $0 | EDGAR |
| 2025-02-10 | ERNA | Grant (A) | — | $0 | EDGAR |
| 2024-06-25 | ERNA | Mixed | +257 | -$349 | EDGAR |
| 2024-04-29 | ERNA | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | ERNA | Mixed | +259 | -$444 | EDGAR |
| 2022-06-23 | BTX | Mixed | +5,164 | -$1.7K | EDGAR |
| 2022-03-17 | BTX | Grant (A) | — | $0 | EDGAR |
| 2022-03-15 | BTX | Grant (A) | — | $0 | EDGAR |
| 2021-06-22 | BTX | Grant (A) | — | $0 | EDGAR |
| 2021-03-26 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −6,094 | -$16.3K | EDGAR |